1 / 26

NHS and HE: Collaboration for the Future NHS – HE Conference 17 November 2011

UCL SCHOOL OF LIFE AND MEDICAL SCIENCES. NHS and HE: Collaboration for the Future NHS – HE Conference 17 November 2011. Professor Sir John Tooke UCL Vice Provost (Health) Head of School of Life and Medical Sciences. NHS-HE Collaboration for the future. Track record and emerging threats

demetrius-galloway
Download Presentation

NHS and HE: Collaboration for the Future NHS – HE Conference 17 November 2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. UCL SCHOOL OF LIFE AND MEDICAL SCIENCES NHS and HE: Collaboration for the FutureNHS – HE Conference17 November 2011 Professor Sir John Tooke UCL Vice Provost (Health) Head of School of Life and Medical Sciences

  2. NHS-HE Collaboration for the future • Track record and emerging threats • How do we retain global competitiveness • Key enablers

  3. NHS-HE Collaboration for the future • Track record and emerging threats • How do we retain global competitiveness • Key enablers

  4. UK performance in terms of citation impact • BIS citation analysis found UK “attracts more citations per pound spent in overall R&D than any other country.” • Independent Thomson Reuters analysis found that UK scientific papers have greatest impact according to average number of citations. • When raw data is adjusted to norms in each field and year of publication, the UK performance surpasses even that of the US, moving from second to first rank in 2007. Source: E Marshall and J Travis, Science Vol. 334, 28 Oct 2011

  5. Growing competition from ‘BIC’ countries Annual growth in GDP spend on R&D 1996-2007 Annual growth in publications 1996-2008 Source: Royal Society, ‘Knowledge, networks and nations’, March 2011

  6. Investment in France • French Initiative d'Excellence (Idex): €7.7 billion (£6.6 billion) invested in scheme to establish five to seven world class ‘academic clusters’. • Proposed "Sorbonne League" will require universities, grandes écoles and France's independent research organisations, to work together. • Universities of Bordeaux, Strasbourg and Paris Sciences et Lettres were selected earlier this year. The Second call for Idex members is under way.

  7. Decline in Pharma • UK share of clinical trials (6% in 2000 → 2% in 2006) • Pfizer exit from UK • Scaling down of GSK presence

  8. Decline in Pharma • Business model ‘broken’ • Regulatory burden • Cost • Limited industrially facing joint endeavours

  9. Financial pressures on Higher Education Institutions and the NHS threaten our common purpose

  10. NHS-HE Collaboration for the future • Track record and emerging threats • How do we retain global competitiveness • Key enablers

  11. How do we retain Global competitiveness in biomedical science? • Harnessing the NHS as a ‘Population laboratory’ • Inter-institutional collaboration

  12. Academic Health Science Centre: UCLPartners • Aims: • Translation of biomedical research into population health gain; • Service transformation - promotion of integrated health care across organisational divides; • Development of leaders equipped to deliver change Barts & The London QMUL

  13. Neuroscience UCLP Research programmes: Cardiovascular Liver & digestive health Infectious diseases Eyes & vision Child health Women’s health Cancer Mental health & wellbeing Immunology & transplantation Ear, nose & throat (ENT) UCL Partners – Achievements 2010-11 Highlights include: • Development of a new cross-sector model of care for acute stroke that has reduced mortality to below 10% in North Central London, against a 22% national average. • Creation of a globally relevant R&D programme in London to develop new treatments for brain cancer. • Development of Whittington Health, a single integrated care organisation spanning primary, community and hospital care, organised around the needs of patients and the local population. • “Open Eyes”. Extension of the application of a groundbreaking, clinically-driven electronic patient records which can be owned by the patient.

  14. Gap 2 Gap 1 • Gap 1: attended to by BRCs • Funding renewed in 2011 • £165m over 5 years • Pursuing greater academic alignment • Gap 2: Translational agenda • Population Health • London Social Enterprise for Health Improvement • Lead Provider PGMET UCL Partners provides context and framework

  15. Academic Health Science Systems as a National Resource • Evidence into practice • ‘Learning organisations’ • Service transformation and integration • PG Medical education and training A variable concentration of biomedical science expertise

  16. Factors associated with high (academic and wider) impact cardiovascular and stroke research Project Retrosight. RAND Europe 2011 Basic biomedical science with clear clinical motivation Collocation (basic in clinical setting) Collaboration (local and international) Engagement with practitioners and patients Industry collaboration

  17. London’s AHSCs Global competitiveness: → Scale → Collaboration / clustering 15 Hospitals 4 Academic partners + Extensive community networks Partners Healthcare (Harvard) 8 Hospitals 2 Academic partners + 1 Rehabilitation network, 1 Home healthcare network, 1 Medical Management Service

  18. London-wide inter-institutional collaboration • The Francis Crick Institute • Imanova • Social Enterprise for Health Improvement

  19. NHS-HE Collaboration for the future • Track record and emerging threats • How do we retain global competitiveness • Key enablers

  20. Key enablers • Political will • Culture and leadership • Stream-lining governance • Bioresources • Informatics

  21. Academy of Medical Sciences report • Report sets out new regulatory and governance pathway to increase speed at which healthcare innovations become available to patients, whilst eliminating unnecessary bureaucracy. • “A fertile research environment is vital for the health and wealth of the UK. The current system of regulation is making it increasingly difficult to initiate health research in the UK and is preventing patients from participating in studies. This is ultimately denying patients early access to new drugs and hindering improvements to public health for the wider society.” Prof Sir Michael Rawlins FMedSci, Chair of the AMS Working Group

  22. Informatics • Electronic health records • Integrated care and research • Bioresources • Access to published knowledge • Clinical decision making • Commissioning • Policy • Research • CPD

  23. The Peter Hill review • Recommended continued collaboration between HE and NHS library services. • Collaboration in London needs to continue to develop.

  24. Potential areas for collaboration • Consolidation of library holdings between NHS and HE • Common open access policy • Joint procurements (AHSS implications) • Digital innovations

  25. Digital innovations • Informatics: • personal access • coaching • remote sensing • data synthesis “The future of cellular telephony is to make people’s lives better – the most important way, in my view, will be the opportunity to revolutionize healthcare” Martin Cooper, inventor of the mobile phone

  26. Conclusions • NHS-HE collaboration is critical for our health service and economy • Harnessing information is the key enabler

More Related